| Inhalable nanoparticle-based dry powder formulations for respiratory diseases: challenges and strategies for translational research HW Chan, S Chow, X Zhang, Y Zhao, HHY Tong, SF Chow AAPS PharmSciTech 24 (4), 98, 2023 | 26 | 2023 |
| Role of particle size in translational research of nanomedicines for successful drug delivery: discrepancies and inadequacies HW Chan, S Chow, X Zhang, PCL Kwok, SF Chow Journal of Pharmaceutical Sciences 112 (9), 2371-2384, 2023 | 11 | 2023 |
| Mediating bio-fate of polymeric cholecalciferol nanoparticles through rational size control J Weng, Z Shao, HW Chan, SPY Li, JKW Lam, CK Tsang, SF Chow Biomaterials Advances 140, 213074, 2022 | 8 | 2022 |
| Expanding the solid-state landscape of dexamethasone: a specific sandwich structure in facilitating the formation of kinetically stable cocrystals from mechanochemistry SN Wong, KH Low, J Weng, HW Chan, SF Chow CrystEngComm 24 (33), 5875-5879, 2022 | 7 | 2022 |
| Physical stability and in vivo brain delivery of polymeric ibuprofen nanoparticles fabricated by flash nanoprecipitation X Zhang, LY Chau, HW Chan, J Weng, KW Wong, SF Chow, AHL Chow International Journal of Pharmaceutics 598, 120224, 2021 | 7 | 2021 |
| Integrated continuous manufacturing of inhalable remdesivir nanoagglomerate dry powders: design, optimization and therapeutic potential for respiratory viral infections HW Chan, HW Lee, S Chow, DCL Lam, SF Chow International Journal of Pharmaceutics 644, 123303, 2023 | 6 | 2023 |
| Synthesis of the first remdesivir cocrystal: design, characterization, and therapeutic potential for pulmonary delivery SN Wong, KH Low, YL Poon, X Zhang, HW Chan, SF Chow International Journal of Pharmaceutics 640, 122983, 2023 | 5 | 2023 |
| Development of Favipiravir Dry Powders for Intranasal Delivery: An Integrated Cocrystal and Particle Engineering Approach via Spray Freeze Drying SN Wong, S Li, KH Low, HW Chan, X Zhang, S Chow, B Hui, PCY Chow, ... International Journal of Pharmaceutics 653, 123896, 2024 | 3 | 2024 |
| Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation HW Chan, X Zhang, S Chow, DCL Lam, SF Chow International Journal of Pharmaceutics 653, 123877, 2024 | 3 | 2024 |
| Development of redispersible remdesivir nanoagglomerate for inhaled therapy: Box-Behnken design, optimization and in vitro aerosol performance HW Chan, SF Chow Controlled Release Society 2022 Annual Meeting and Exposition, 2022 | 1 | 2022 |
| Rational Development of Fingolimod Nano-embedded Microparticles as Nose-to-Brain Neuroprotective Therapy for Ischemic Stroke X Zhang, G Su, Z Shao, HW Chan, S Li, S Chow, CK Tsang, SF Chow | | 2024 |
| Storage stability of lysostaphin solution and its pulmonary delivery P Zeng, P Zhang, HW Chan, SF Chow, JKW Lam, M Ip, SSY Leung Drug Delivery and Translational Research 14 (9), 2433-2443, 2024 | | 2024 |
| Development and characterization of flufenamic acid cocrystals for potential topical delivery B Xuan, HW Chan, PS Lo, R Lakerveld, SF Chow Controlled Release Society 2022 Annual Meeting and Exposition, 2022 | | 2022 |
| Rational design and fabrication of paclitaxel-curcumin nanosuspensions as a potential inhaled therapy for non-small cell lung cancer HW Chan, X Zhang, SF Chow Controlled Release Society 2022 Annual Meeting and Exposition, 2022 | | 2022 |
Shing Fung CHOW, AvivaThe University of Hong Kong在 hku.hk 的电子邮件经过验证
